Watching Trump from afar, Israel fears being left out of a new Middle East it helped create
For decades, Israel has leveraged its special relationship with the United States to serve as a gatekeeper to Washington. From the Camp David Treaty with Egypt to the Abraham Accords brokered by Trump in his first term, Arab states seeking U.S. favor usually had to first make nice with Israel. And rarely did their interests prevail if they clashed with Israel's.
But on Wednesday, to Israel's dismay, Saudi Arabia and Turkey brokered a historic meeting between Trump and Syria's new president, and Trump portrayed his decision to lift sanctions on Damascus as a favor to his host, Saudi Crown Prince Mohammed bin Salman, and Turkish President Recep Tayyip Erdogan.
Israel, which still views Syria as a security threat and had urged Trump to keep the sanctions in place, was ignored, as it apparently was on a number of recent U.S. initiatives in the region, from the ongoing talks with Iran to the ceasefire with Yemen's Houthi rebels. Asked Friday if he knew Israel opposes U.S. recognition of Syria's new government, Trump replied: 'I don't know, I didn't ask them about that.'
'This week there was a party in the Middle East — a grand ball full of colorful costumes, money and gold changing hands — and we found ourselves playing the role of Cinderella before the transformation,' columnist Sima Kadmon wrote in Israel's Yediot Ahronot daily.
'The fairy godmother we thought we had flew off to Saudi Arabia and Qatar.'
Trump skipped Israel on his first major foreign tour, which instead took him to Saudi Arabia, Qatar and the United Arab Emirates.
Israel was also left out of a deal with Hamas to free an American hostage from Gaza, where Israel is trying to destroy the militant group. Trump reached a separate truce with Yemen's Houthi rebels that has allowed them to train their fire on Israel, and is holding talks with Iran on its nuclear program that could bring about another deal that Israel rejects.
There have been no open clashes between Trump and Israeli Prime Minister Benjamin Netanyahu, both of whom say relations have never been better. Trump has yet to scold Israel, at least in public, as former President Biden occasionally did, over civilian deaths in the Gaza Strip.
But compared with Trump's first term, when he upended decades of U.S. foreign policy to lend unprecedented support to Israel, something has changed.
This time around, Trump seems to be hunting for quick wins — big investment deals to boost the American economy and diplomatic agreements like the India-Pakistan ceasefire and the release of hostages.
In that respect, Netanyahu has little to offer.
Israel's 19-month military campaign in Gaza has killed tens of thousands of Palestinians and reduced entire towns to rubble but has yet to achieve either of Netanyahu's war aims — the defeat of Hamas and the return of all the hostages taken in the Oct. 7, 2023, attack that ignited the war.
Netanyahu has refused to end the war in exchange for the release of the remaining hostages, or to accept a pathway to Palestinian statehood — key Saudi demands for the kind of historic normalization accord that Trump has long sought.
'Trump has given Israel many opportunities, and ammunition prohibited by the Biden administration, to end the war in Gaza. This is what Trump wants,' said Eytan Gilboa, an expert on U.S.-Israeli relations at Israel's Bar-Ilan and Reichman universities. Instead, the war is intensifying.
'Netanyahu is coming closer to the status of a loser in Trump's eyes,' Gilboa said.
Trump has downplayed any rift, telling reporters on the tour that his relationships with regional leaders are 'good for Israel.'
The irony is that Israel is being excluded from a regional realignment that it largely created, by inflicting punishing losses on Iran and its allies after the Oct. 7 attack. Its thrashing of Hezbollah in Lebanon hastened the downfall of Syrian President Bashar Assad, and Iran may be more open to concessions on its nuclear program after a wave of Israeli retaliatory strikes last year.
Michael Oren, a historian and former Israeli ambassador to the U.S., said there is at least one precedent for Trump's approach.
'It's going to drive the people in Washington crazy, but it most closely resembles the Obama administration,' he said.
On Barack Obama's first visit as president to the Middle East, he too skipped Israel. Oren, a critic of that administration who was Israel's envoy to the U.S. at the time, said Obama repeatedly violated an unspoken rule of U.S.-Israeli relations — that there be no surprises. That led to public spats with Netanyahu, especially around the 2015 Iranian nuclear deal.
Few expect a repeat under Trump — or that he will publicly press Israel to wind down the war in Gaza, despite the humanitarian catastrophe unleashed by its war and blockade.
Trump has said the days of the United States giving 'lectures' to Middle Eastern countries are over — that decades of American intervention have done more harm than good.
And the Israeli-Palestinian conflict is the last place any American president would look for a quick win.
'He's not looking for a fight with Israel,' Oren said. 'He wants to end the war, but the war can end in different ways.'
Krauss writes for the Associated Press.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Epoch Times
28 minutes ago
- Epoch Times
Trump Wants to Change Census to Exclude Illegal Immigrants—What to Know
President Donald Trump is seeking to change how the U.S. Census Bureau collects data and exclude illegal immigrants from the U.S. Census. Trump ordered the Commerce Department to do so and announced the plan via a post to Truth Social, writing that the department would begin work on a 'new and highly accurate CENSUS based on modern day facts and figures and, importantly, using the results and information gained from the Presidential Election of 2024.'


CNBC
28 minutes ago
- CNBC
Healthy Returns: FDA launches program to streamline creation of new U.S. drug manufacturing sites
A new program from the Trump administration aims to make setting up manufacturing plants in the U.S. less of a headache for the pharmaceutical industry. The Food and Drug Administration on Thursday announced a new "PreCheck" program, which will use a two-phase approach to help boost domestic drug manufacturing after it shrunk dramatically over the past two decades. The announcement is a direct response to President Donald Trump's executive order in May calling on the FDA to reduce regulatory hurdles for domestic drug production in the U.S.. That order asked the agency to cut the amount of time it takes to approve new plants by eliminating unnecessary requirements, while also increasing the fees for and inspections of manufacturing facilities abroad. It follows a flurry of plans for new U.S. manufacturing investments from several drugmakers, such as Johnson & Johnson, AbbVie and Eli Lilly, in a bid to build goodwill with Trump. Still, the president could impose tariffs on pharmaceuticals imported into the U.S. any day now — a move that the industry argues could harm innovation and patient access to certain treatments. So, why has Trump made reshoring drug production a key facet of his trade policy? More than half of pharmaceuticals distributed in the U.S. are manufactured overseas, according to a release from the FDA. Only 11% of companies that produce active pharmaceutical ingredients are based in the U.S., while a significant share are in China and India, the agency added. The White House also estimates that it can currently take five to 10 years to build new manufacturing capacity for pharmaceuticals, which it previously called "unacceptable from a national-security standpoint." "Our gradual overreliance on foreign drug manufacturing has created national security risks," FDA Commissioner Dr. Marty Makary said in the release on Thursday. "The FDA PreCheck initiative is one of many steps FDA is taking that can help reverse America's reliance on foreign drug manufacturing and ensure that Americans have a resilient, strong, and domestic drug supply." Here's how the two phases of the program work: The FDA will host a public meeting on Sept. 30, where it will present on the program and discuss other proposals to "overcome current onshoring challenge," among other issues. Until then, concrete details on the program are sparse. It's unclear what requirements the FDA could eliminate, and how much less time it could take to approve new sites. We'll continue to watch as this program gets finalized and implemented, so stay tuned for our coverage! Feel free to send any tips, suggestions, story ideas and data to Annika at Like it or not, more and more patients are turning to OpenAI's artificial intelligence chatbot ChatGPT to answer questions about their health care. And the company is paying attention. OpenAI launched its latest large-scale AI model called GPT-5 last week, and the startup said it's the "best model yet" for health-related queries. The product is designed to proactively flag health concerns, ask relevant questions and generate more precise and reliable responses, the company said in a blog post. "Health care is maybe the area where there's the strongest improvement of any (is this one extra?) of any category," OpenAI CEO Sam Altman told CNBC's "Squawk Box" in an interview about GPT-5 on Friday. Altman said health-related questions make up a "huge fraction" of ChatGPT usage. In a post on X, he said he hopes GPT-5's health capabilities will "provide real service to people." OpenAI said GPT-5 scores "significantly higher" than previous models on its health-care AI benchmark called Health Bench. The company released Health Bench in May, and it's designed to measure how well AI models perform in realistic health scenarios. HealthBench was developed alongside 262 doctors from 60 countries. OpenAI said it's based on 5,000 conversations that simulate interactions between individual users or clinicians and AI models. OpenAI is also touting GPT-5 as a helpful tool for medical research. The company released a two-minute-long video with Dr. Derya Unutmaz, a professor and human immunologist, which demonstrates how he has been using the model. Unutmaz said GPT-5 is able to help him brainstorm, interpret data and save him time by predicting outcomes of potential experiments. "I think GPT-5 will help the patients to advocate for themselves, and I think that will empower the patients to feel more confident when they talk to their doctors," Unutmaz said in the video. Feel free to send any tips, suggestions, story ideas and data to Ashley at


USA Today
29 minutes ago
- USA Today
Newsom mocks Trump in all-caps post promising a 2026 Democratic victory
California Gov. Gavin Newsom mocked President Donald Trump with an all-caps tweet amid a heated redistricting effort in Texas. WASHINGTON − California Democratic Gov. Gavin Newsom mocked President Donald Trump with an all-caps tweet amid a heated redistricting effort in Texas that could give Republicans up to five more seats in the U.S. House of Representatives next year. Mimicking Trump's all-caps social media style, Newsom trolled the president as "DONALD 'TACO' TRUMP," and suggested California would soon go forward with its own redistricting effor to offset the Republican effort in Texas. The post comes as Newsom urged Trump in an Aug. 11 letter to stop the redistricting efforts, arguing that Trump was 'playing with fire' and 'risking the destabilization of our democracy.' Newsom added that if Trump doesn't stand down, he would redraw the congressional map in California to counter the Texas effort. 'DONALD 'TACO' TRUMP, AS MANY CALL HIM, 'MISSED' THE DEADLINE!!! CALIFORNIA WILL NOW DRAW NEW, MORE 'BEAUTIFUL MAPS,' THEY WILL BE HISTORIC AS THEY WILL END THE TRUMP PRESIDENCY (DEMS TAKE BACK THE HOUSE!). BIG PRESS CONFERENCE THIS WEEK WITH POWERFUL DEMS AND GAVIN NEWSOM — YOUR FAVORITE GOVERNOR — THAT WILL BE DEVASTATING FOR 'MAGA.' THANK YOU FOR YOUR ATTENTION TO THIS MATTER! — GN,' Newsom wrote on X, imitating Trump's language in his Truth Social posts. "TACO," an acronym for "Trump Always Chickens Out," is a reference to Trump's ever-shifting tariff deadlines. Newsom's post received more than 3.2 million views. Democratic governors Kathy Hochul of New York and J.B. Pritzker of Illinois have also previously threatened to launch their own redistricting efforts that could give Democrats a boost, sparking a tit-for-tat. Redistricting is required by federal law every 10 years following the release of new U.S. Census Bureau figures. However, Trump encouraged Texas Republicans to jumpstart the process in the middle of the decade. The Texas Senate on Aug. 12 approved the new set of congressional lines by a vote of 19-2, according to the Texas Tribune. The Texas redistricting effort is stalled in the state House, where most Democratic representatives have fled the state, denying majority Republicans a quorum needed to pass the measure. Trump said Aug. 5 that Republicans "are entitled to five more seats" in Texas because of his 2024 election victory there. Republicans currently hold the U.S. House by a razor thin margin. Newsom said that he is eyeing a special election in November so voters could weigh in on a ballot measure that would allow for a new House map in California ahead of the 2026 midterms.